Figure 1.
Distribution of ERBB2 alterations across diseases. Mutations, amplifications, and rearrangements involving ERBB2 were identified in 403 tumors across 27 disease types. Data are expressed as a percentage compared with the total number of tumors within that subtype in our data set.
Abbreviations: cholangio, cholangiocarcinoma; GE, gastroesophageal.
